POSTERS ESMO 2024

Cáncer urotelial

Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC)

Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC)

Poster Bd #: 1982P

Poster

Descargar poster

Autor
Begoña Pérez Valderrama

Hospital Universitario Virgen del Rocío. Sevilla

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON